A retrospective efficacy and safety study of pembrolizumab/cetuximab neoadjuvant therapy in locally advanced hypopharyngeal cancer
PurposeThe primary objective of this study was to retrospectively assess the efficacy and safety profiles of two neoadjuvant regimens combining either pembrolizumab or cetuximab with paclitaxel and cisplatin in patients with locally advanced hypopharyngeal cancer (LAHPC).MethodsLAHPC patients who re...
Saved in:
| Main Authors: | Guangnan Yao, Xiaobo Wu, Hanqing Lin, Zhihong Chen, Chang Lin, Gongbiao Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574988/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Excellent response of cetuximab plus chemotherapy after pembrolizumab monotherapy in metastatic hypopharyngeal cancer: A case report
by: Anh Tuan Pham, et al.
Published: (2025-03-01) -
Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
by: Guoning Yu, et al.
Published: (2025-06-01) -
Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma
by: Suling Zhuang, et al.
Published: (2025-07-01) -
Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer
by: Gaofei Yin, et al.
Published: (2025-02-01) -
miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer
by: Shiyun Chen, et al.
Published: (2025-05-01)